Effectiveness of tipranavir versus darunavir as a salvage therapy in HIV-1 treatment-experienced patients

Although both tipranavir (TPV) and darunavir (DRV) represent important options for the management of patients with multi-protease inhibitor (PI)-resistant human immunodeficiency virus (HIV), currently there are no studies comparing the effectiveness and safety of these two drugs in the Mexican popul...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of infection in developing countries 2016-09, Vol.10 (9), p.982-987
Hauptverfasser:	Domínguez-Hermosillo, Juan Carlos, Mata-Marin, José Antonio, Herrera-González, Norma Estela, Chávez-García, Marcelino, Huerta-García, Gloria, Nuñez-Rodríguez, Nohemí, García-Gámez, José Gerardo, Jiménez-Romero, Anai, Gaytán-Martínez, Jesús Enrique
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anti-HIV Agents - adverse effects Anti-HIV Agents - therapeutic use Antiretroviral drugs Cohort Studies Darunavir - adverse effects Darunavir - therapeutic use Drug resistance Female HIV HIV Infections - drug therapy HIV-1 - isolation & purification Human immunodeficiency virus Humans Male Mexico Middle Aged Prospective Studies Pyridines - adverse effects Pyridines - therapeutic use Pyrones - adverse effects Pyrones - therapeutic use Salvage Therapy - methods Treatment Outcome Viral Load Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!